Reserved
Reserved
Novavax rimbalza dell'8,6%, ma il flusso di denaro continua a peggiorare
EXECUTIVE VIEW
Analisi tecnica settimanale di Novavax: le azioni rimbalzano dell'8,6% con l'84% dei volumi in acquisto, ma il flusso di denaro peggiora e il trend ribassista perde forza. Lo short resta in guadagno, oltre il 10%.
Reserved analysis
Subscribe to read →
Novavax stock rebounds 8.6%, yet money flow keeps deteriorating
EXECUTIVE VIEW
Novavax stock technical analysis: shares bounce 8.6% on strong buying volume, yet money flow keeps deteriorating for this pharma stock. The Sell signal's short stays in the money, above 10%, as the downtrend loses conviction.
Reserved analysis
Subscribe to read →